Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quantitative Subharmonic Breast Imaging
NCT01490892Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- Nov 2011
- Primary completion
- Apr 2019
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of perflutren in breast cancer, sponsored by Thomas Jefferson University. Started Nov 2011; status: completed.
02
Drugs
perflutren
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01490892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490892.